Intraoperative integration of artificial intelligence during cystoscopic surgery
Intraoperative integration of artificial intelligence during cystoscopic surgery
批准号:
10544344
负责人:
JOSEPH C LIAO
金额:
$49.61万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2022
资助国家:
美国
项目状态:
未结题
起止时间:
2022-01-01 至 2026-12-31
关键词:
AffectAlgorithmsAppearanceArtificial IntelligenceBase SequenceBenignBladderBladder NeoplasmCancer DetectionCancer DiagnosticsCancer PatientCancerousCessation of lifeClinicClinicalCommunitiesComplexComputer Vision SystemsCystoscopyDataData SetDetectionDiagnosisDiagnosticDiagnostic SensitivityEnsureEnvironmentEquipmentExcisionFutureGoalsHealthcareHistologicHospitalsHumanImageImage AnalysisInflammatoryInterventionKnowledgeLearningLesionLightMalignant NeoplasmsMalignant neoplasm of urinary bladderMedical ImagingMedical centerModelingMorbidity - disease rateMorphologyNewly DiagnosedOperating RoomsOperative Surgical ProceduresOutcomePapillaryPathologicPatientsPerformancePhysician AssistantsPredictive ValueProcessProtocols documentationProviderRecurrenceRecurrent Malignant NeoplasmResearchRoleSiteSpecificityStagingStandardizationSurgeonTechnologyTestingThe Cancer Imaging ArchiveTimeTrainingTranslatingTransurethral ResectionUnited StatesUniversitiesUrologistUrologyValidationWashingtonWorkannotation systemaugmented intelligenceautomated segmentationbody systemcancer diagnosiscancer imagingcancer recurrencecancer riskcancer surgerycare burdencloud basedconvolutional neural networkcost effectivedeep learning algorithmdeep neural networkdemographicsdesignexperiencehigh riskimage guidedimage processingimprovedimproved outcomeindexingmillisecondmortalitymultidisciplinaryneuralnovelpatient stratificationprospectiverecruitrecurrent neural networkrisk stratificationscreeningsegmentation algorithmtooltumortumor progression
中文摘要
点击翻译按钮获取中文摘要
英文摘要
PROJECT SUMMARY
Bladder cancer is the sixth most common cancer in the U.S., has one of the highest recurrence rates of all
cancers, and is the most expensive cancer to treat from diagnosis to death. Current standard for bladder
cancer diagnosis relies on clinic-based white light cystoscopy for initial screening, followed by transurethral
resection of bladder tumor in the operating room for pathologic diagnosis and local staging. White light
cystoscopy has several well recognized shortcomings, particularly incomplete detection, thereby leading to
suboptimal resection and contributing to cancer recurrence and progression. Our goal is to improve outcomes
for bladder cancer patients through integration of a deep learning algorithm to improve cystoscopic detection
and enhance surgical resection.
Artificial intelligence (AI)-based on deep neural networks have demonstrated remarkable capacity to learn
complex relationships and incorporate existing knowledge into the inference model. We hypothesize that AI-
augmented detection of bladder tumor will improve diagnostic cystoscopy in the clinic setting to identify
suspicious lesions and improve the quality of transurethral resection in the operating room, thereby reducing
overall cancer recurrence and outcome. Towards the goal of establishing a paradigm of AI-based framework
for augmented detection of bladder cancer, we will leverage our strong preliminary data and outstanding
environment in AI research. We propose three specific aims: 1) To curate a high-quality annotated cystoscopy
imaging dataset to optimize deep neural network CystoNet; 2) To design and optimize CystoNet for real-time
cystoscopic navigation and cancer detection; and 3) To conduct a prospective multicenter validation of
CystoNet during bladder cancer surgery.
Successful completion of the studies proposed here will serve to translate deep learning algorithm to the
dynamic environment of cystoscopic surgery without the need for specialized instrumentaitons. We foresee
our approach will improve the outcome of a major cancer and genearlizable to other organ systems amenable
for endsocopic interventions.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Intraoperative integration of artificial intelligence during cystoscopic surgery
-
批准号:10365872
-
项目类别:
-
资助金额:$51.4万
-
财政年份:2022
-
负责人:JOSEPH C LIAO
-
依托单位:
BCCMA: Basic and Translational Mechanisms of Cancer Initiation of the Urothelium in Veterans Exposed to Carcinogens: Leveraging Artificial Neural Networks to Enhance Detection of Carcinoma in situ
-
批准号:10260145
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2021
-
负责人:JOSEPH C LIAO
-
依托单位:
MagSToNE - a magnetic system for kidney stone fragment elimination
-
批准号:10354258
-
项目类别:
-
资助金额:$19.68万
-
财政年份:2021
-
负责人:JOSEPH C LIAO
-
依托单位:
MagSToNE - a magnetic system for kidney stone fragment elimination
-
批准号:10491338
-
项目类别:
-
资助金额:$23.81万
-
财政年份:2021
-
负责人:JOSEPH C LIAO
-
依托单位:
BCCMA: Basic and Translational Mechanisms of Cancer Initiation of the Urothelium in Veterans Exposed to Carcinogens: Leveraging Artificial Neural Networks to Enhance Detection of Carcinoma in situ
-
批准号:10513315
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2021
-
负责人:JOSEPH C LIAO
-
依托单位:
Personalized assessment of bladder cancer treatment response using urinary molecular biomarkers
-
批准号:10514572
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2020
-
负责人:JOSEPH C LIAO
-
依托单位:
Personalized assessment of bladder cancer treatment response using urinary molecular biomarkers
-
批准号:10293596
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2020
-
负责人:JOSEPH C LIAO
-
依托单位:
Personalized assessment of bladder cancer treatment response using urinary molecular biomarkers
-
批准号:10015540
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2020
-
负责人:JOSEPH C LIAO
-
依托单位:
A Droplet-based single cell platform for pathogen identification and AST
-
批准号:8875827
-
项目类别:
-
资助金额:$125.64万
-
财政年份:2015
-
负责人:JOSEPH C LIAO
-
依托单位:
A Droplet-based single cell platform for pathogen identification and AST
-
批准号:9038992
-
项目类别:
-
资助金额:$118.49万
-
财政年份:2015
-
负责人:JOSEPH C LIAO
-
依托单位:
Optical Imaging of Bladder Cancer with Molecular Contrast Agents
-
批准号:8309089
-
项目类别:
-
资助金额:$43.42万
-
财政年份:2011
-
负责人:JOSEPH C LIAO
-
依托单位:
Optical Imaging of Bladder Cancer with Molecular Contrast Agents
-
批准号:8677802
-
项目类别:
-
资助金额:$41.51万
-
财政年份:2011
-
负责人:JOSEPH C LIAO
-
依托单位:
Optical Imaging of Bladder Cancer with Molecular Contrast Agents
-
批准号:8160231
-
项目类别:
-
资助金额:$45.25万
-
财政年份:2011
-
负责人:JOSEPH C LIAO
-
依托单位:
Optical Imaging of Bladder Cancer with Molecular Contrast Agents
-
批准号:8464674
-
项目类别:
-
资助金额:$41.23万
-
财政年份:2011
-
负责人:JOSEPH C LIAO
-
依托单位:
An Integrated Diagnostic Biochip for Point of Care Pathogen Identification
-
批准号:7784500
-
项目类别:
-
资助金额:$73.07万
-
财政年份:2009
-
负责人:JOSEPH C LIAO
-
依托单位:
An Integrated Diagnostic Biochip for Point of Care Pathogen Identification
-
批准号:8015997
-
项目类别:
-
资助金额:$86.93万
-
财政年份:2009
-
负责人:JOSEPH C LIAO
-
依托单位:
An Integrated Diagnostic Biochip for Point of Care Pathogen Identification
-
批准号:8215883
-
项目类别:
-
资助金额:$68.48万
-
财政年份:2009
-
负责人:JOSEPH C LIAO
-
依托单位:
An Integrated Diagnostic Biochip for Point of Care Pathogen Identification
-
批准号:7650486
-
项目类别:
-
资助金额:$75.64万
-
财政年份:2009
-
负责人:JOSEPH C LIAO
-
依托单位:
An Integrated Diagnostic Biochip for Point of Care Pathogen Identification
-
批准号:8435494
-
项目类别:
-
资助金额:$63.9万
-
财政年份:2009
-
负责人:JOSEPH C LIAO
-
依托单位:
海外基金